BioCatalyst

SP-101 and doxorubicin Cohort 1, SP-101 and doxorubicin Cohort 2 — catalyst calendar

1 verified catalyst event(s) referencing SP-101 and doxorubicin Cohort 1, SP-101 and doxorubicin Cohort 2, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 3mo
ESTIMATED
 READOUT
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Phase 1/2 · Cystic Fibrosis
 Spirovant Sciences, Inc. SP-101 and doxorubicin Cohort 1, SP-101 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.